3.27
+0.09(+2.83%)
Currency In USD
| Previous Close | 3.18 |
| Open | 3.27 |
| Day High | 3.29 |
| Day Low | 3.1 |
| 52-Week High | 6.01 |
| 52-Week Low | 1.12 |
| Volume | 267,848 |
| Average Volume | 419,212 |
| Market Cap | 64.3M |
| PE | -1.48 |
| EPS | -2.21 |
| Moving Average 50 Days | 2.9 |
| Moving Average 200 Days | 2.76 |
| Change | 0.09 |
If you invested $1000 in NRx Pharmaceuticals, Inc. (NRXP) since IPO date, it would be worth $33.13 as of October 20, 2025 at a share price of $3.18. Whereas If you bought $1000 worth of NRx Pharmaceuticals, Inc. (NRXP) shares 5 years ago, it would be worth $0.29 as of October 20, 2025 at a share price of $3.18.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
GlobeNewswire Inc.
5 hours ago
Cohen and Associates has more than a decade of leadership in interventional psychiatry and Transcranial Magnetic Stimulation (TMS) Dr. Rebecca Cohen has joined HOPE as Medical DirectorImmediate expansion is planned in Western Florida and Palm BeachAc
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
GlobeNewswire Inc.
Oct 06, 2025 12:03 PM GMT
WILMINGTON, Del., Oct. 06, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), an interven
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
GlobeNewswire Inc.
Sep 29, 2025 12:03 PM GMT
KETAFREE™ to provide innovative, preservative-free IV ketamine formulation, eliminating toxic preservatives, in keeping with current HHS priorities to eliminate toxic preservatives from foods and drugsFiling is based on FDA interaction and approval o